Pharmacopoeia Reference: In house having US DMF Type IV, IIG listed
Technical Specifications: Ready to use liquid polymer for topical applications (Gel / Cream / Lotion/ Foam based formulation, etc); It thickens over a wide range of pH 3-12; No HLB Calculation; No Neutralization
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**